These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20347023)

  • 1. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system.
    Tahara K; Furukawa S; Yamamoto H; Kawashima Y
    Int J Pharm; 2010 Jun; 392(1-2):311-3. PubMed ID: 20347023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery.
    Tahara K; Yamamoto H; Kawashima Y
    Eur J Pharm Biopharm; 2010 Jun; 75(2):218-24. PubMed ID: 20332026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
    Zeng P; Xu Y; Zeng C; Ren H; Peng M
    Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells.
    Tahara K; Kato Y; Yamamoto H; Kreuter J; Kawashima Y
    J Microencapsul; 2011; 28(1):29-36. PubMed ID: 21171814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
    Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
    Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
    Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
    Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of cationic chitosan-modified poly(D,L-lactide-co-glycolide) copolymer nanospheres as DNA carriers.
    Guan XP; Quan DP; Liao KR; Tao Wang ; Peng Xiang ; Mai KC
    J Biomater Appl; 2008 Jan; 22(4):353-71. PubMed ID: 17494965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
    Tahara K; Yamamoto H; Hirashima N; Kawashima Y
    Eur J Pharm Biopharm; 2010 Mar; 74(3):421-6. PubMed ID: 20034563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
    Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM
    Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocytosis-like uptake of surface-modified drug nanocarriers into giant unilamellar vesicles.
    Tahara K; Tadokoro S; Kawashima Y; Hirashima N
    Langmuir; 2012 May; 28(18):7114-8. PubMed ID: 22515197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.
    Takashima Y; Saito R; Nakajima A; Oda M; Kimura A; Kanazawa T; Okada H
    Int J Pharm; 2007 Oct; 343(1-2):262-9. PubMed ID: 17628365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods.
    Kawashima Y; Yamamoto H; Takeuchi H; Hino T; Niwa T
    Eur J Pharm Biopharm; 1998 Jan; 45(1):41-8. PubMed ID: 9689534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particle size control of poly(dl-lactide-co-glycolide) nanospheres for sterile applications.
    Tsukada Y; Hara K; Bando Y; Huang CC; Kousaka Y; Kawashima Y; Morishita R; Tsujimoto H
    Int J Pharm; 2009 Mar; 370(1-2):196-201. PubMed ID: 19100320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in transfection efficiency with chitosan modified poly(DL-lactide-co-glycolide) nanospheres prepared by the emulsion solvent diffusion method, for gene delivery.
    Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
    Chem Pharm Bull (Tokyo); 2011; 59(3):298-301. PubMed ID: 21372409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles.
    Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P
    Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled assembly of poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres under ultrasonic irradiation.
    Jevtić M; Radulović A; Ignjatović N; Mitrić M; Uskoković D
    Acta Biomater; 2009 Jan; 5(1):208-18. PubMed ID: 18753023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface modification of PLGA microspheres.
    Müller M; Vörös J; Csúcs G; Walter E; Danuser G; Merkle HP; Spencer ND; Textor M
    J Biomed Mater Res A; 2003 Jul; 66(1):55-61. PubMed ID: 12833431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.